Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
24 January 2019 | Story Zama Feni | Photo Barend Nagel
Prof Matlabisa
Prof Motlalepula Matlabisa of the Department of Pharmacology.

Two South African government departments have granted the University of the Free State’s Department of Pharmacology a combined amount of R15 million for the establishment of four tea farms in the disadvantaged communities in the North West and Eastern Cape Communities.

The head of the project Prof Motlalepula Matsabisa at the Department of Pharmacology said that that Department of Environmental Affairs (DEA) has granted an amount of R10 million for the community research in the respective provinces.

This grant is a top up to the R5 million they received from the Department of Science and Technology for the “community implementation on indigenous health infusions or teas as commonly known.”

The DEA will in the near future sign a Memorandum of Agreement (MOA) with the university.


Tea project set to empower communities


“The project is to implement and build structures in the four communities we work with in the North West and Eastern Cape,” he said.

The identified areas for the project are in the Eastern Cape towns of Alice and Idutywa as well another two North West communities in Zeerust.

Prof Matsabisa indicated that the project will be a manifestation of “how science can contribute to economic growth, poverty alleviation and job creation.” 

“It was very interesting to have discovered that some French and German companies have already displayed interest in the projects,” he said.

He stated that a project of this nature is a good initiative by the UFS and it will also show that the university’s research activities are national. “We have been researching and developing indigenous teas which have now attracted interest locally and internationally by huge companies such as Nestle, Tiger Brands, Moringa World etc,” he said. 


Taking it slowly


At the initial stages of the tea farming project, Prof Matsabisa said they would start in small portions of utilising five hectares in each of the four projects and as the project gains momentum, they would expand.

Prof Matlabisa said that an environmental impact assessment has already been conducted and they were waiting for the DEA to give them a go ahead for the land preparations.



News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept